logo
Select company
Select metric
0.68Cash Ratio
VS
Market
57
Sector
32
Industry
17
History
10
$ 11.84Close
$ 6.99 - $ 13.14 52-Week Range
Ticker Information

Ticker

AUPH

Company Name

AURINIA PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

AURINIA PHARMACEUTICALS INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AUPH - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 53M0.68$ 78.27M
3/31/2025$ 66.43M0.97$ 68.41M
12/31/2024$ 83.43M0.85$ 97.76M
9/30/2024$ 37.14M0.47$ 78.61M
6/30/2024$ 33.41M0.43$ 76.9M
3/31/2024$ 64.46M0.91$ 71.05M
12/31/2023$ 48.88M0.63$ 77.19M
9/30/2023$ 46.4M0.63$ 73.89M
6/30/2023$ 81.71M1.33$ 61.66M
3/31/2023$ 89M2.12$ 42.05M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AURINIA PHARMACEUTICALS INC's latest trailing twelve months (TTM) Cash Ratio stands at 10.41.
  • Over the past 5 years, AURINIA PHARMACEUTICALS INC's average Cash Ratio has been 2.96.
  • The median Cash Ratio for AURINIA PHARMACEUTICALS INC during this period was 1.79
  • AURINIA PHARMACEUTICALS INC reached its highest Cash Ratio over the past 5 years at 10.41.
  • The lowest Cash Ratio recorded by AURINIA PHARMACEUTICALS INC in the same timeframe 0.43

AURINIA PHARMACEUTICALS INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
RCUS : ARCUS BIOSCIENCES INC 1.18XERS : XERIS BIOPHARMA HOLDINGS INC 0.62MNKD : MANNKIND CORP 0.52IOVA : IOVANCE BIOTHERAPEUTICS INC 1.07DNA : GINKGO BIOWORKS HOLDINGS INC 2.1INVA : INNOVIVA INC 1.61VCEL : VERICEL CORP 1.96ARQT : ARCUTIS BIOTHERAPEUTICS INC 0.7TVTX : TRAVERE THERAPEUTICS INC 0.4AKBA : AKEBIA THERAPEUTICS INC 1.16

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for AURINIA PHARMACEUTICALS INC is calculated as follows: CashnEq [ $ 248.76M ] / LiabilitesC [ $ 23.89M ]
(=) Cash Ratio [ 10.41 ]

AUPH - Cash Ratio, Last 5 years

0.43

Minimum

Jun 30, 2024

10.41

Maximum

Sep 30, 2020

2.96

Average

1.79

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63